MedTrace Logo

uSafeUS+ App Pilot Testing

NCT07557745 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-05-15

No results posted yet for this study

Summary

The purpose of this study is to test the feasibility and acceptability of an innovative mobile application (uSafeUS+) to reduce college student drinking and sexual assault (SA) risk in real time. Following an initial period of app development, this study will use a pilot 3-arm randomized controlled trial (N = 90; 30/arm) to examine the acceptability, feasibility, and initial evidence of efficacy of the novel, expanded uSafeUS+ app, relative to the existing SA-only focused uSafeUS app (already in use on 24 college campuses), and an assessment-only control condition.

Specifically, the investigators aim to answer the following research questions:

1. Do students like the app (overall and specific features)?
2. How frequently do students use the app within the 1-month exposure period?
3. What barriers and facilitators impact app use?
4. Is there evidence of increased use of protective behaviors on drinking days and over time?
5. Is there evidence of decreased drinking (amount, frequency) or SA risk on drinking days and over time?

Participants will complete:

* A baseline assessment
* A 1-month app exposure period with daily surveys about app use on the weekends
* Follow-up surveys at 1- and 2-months post-intervention.

Conditions

  • Alcohol Consumption
  • Sexual Assault

Interventions

BEHAVIORAL

uSafeUS+

uSafeUS app

BEHAVIORAL

uSafeUS

uSafeUS app

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • University of New Hampshire

    collaborator OTHER

  • University of Florida

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-11
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07557745 on ClinicalTrials.gov